Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.51 +2.80%   SPY: 131.97 +1.72%
Quote Spy EPIX NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


EPIX Pharmaceuticals (EPIX)

@ May-21
Click the portfolio to add EPIX:
Close [X]
+ Add EPIX to Portfolio
  
  Last Trade: $0.00 0.00 (0.00%)
  Volume: 321,103 392% of avg daily volume
       
  Avg Volume: 81,966
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 0.00 - 0.00
  Open: 0.00
  Previous Close: 0.00
  52-wk Range: 0.00 - 0.01
  Market Cap: 119.6K
  P/E: -0.0
  Div Yield: $0.00 (0.00%)
Indexes
None
Spy EPIX

? Pro holders
? Member holders
? Items submitted
Additional EPIX resources



Customize Links
To see which Pros and tickerspy members own EPIX Sign up now
Latest EPIX Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Stocks Set to Finish 2010 Strong After Some Profit-Taking
CVX  CHD  TYC  EPIX  PCLN  [ATLS]  ATLS  
Linked by tickerspy Newswire - November 09, 04:46PM from (www.tickerspy.com)
Stocks tumbled on the day as the dollar continued to creep higher on a generally quiet day. Given the strong run equities  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Many Biotechs Barely On Life Support
IDMI  [NRGN]  CEGE  LJPC  NFLDQ  BPAX  EPIX  RPTP  
Linked by 24/7 Wall St. - May 13, 12:31PM from (feedproxy.google.com)
We have run a watch list of companies under their own strategic review, and the number of biotech (or grouped with biotech)  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
EPIX Pharmaceuticals Announces First Quarter 2009 Financial Results
EPIX  
Linked by BusinessWire - May 11, 04:15PM from (www.businesswire.com)
EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX) a biopharmaceutical company focused on discovering and developing novel therapeutics  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
EPIX Pharmaceuticals Announces Final Results of Exchange Offer for $100 Million Convertible Notes
EPIX  
Linked by BusinessWire - May 05, 08:08AM from (www.businesswire.com)
EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
EPIX Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results
EPIX  
Linked by BusinessWire - March 12, 09:00AM from (www.businesswire.com)
EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX) a biopharmaceutical company focused on discovering and developing novel therapeutics  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
EPIX Pharmaceuticals Announces Fourth Quarter and Full Year 2008 Financial Results Release Date and Conference Call
EPIX  
Linked by BusinessWire - March 05, 04:05PM from (www.businesswire.com)
EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
EPIX Pharmaceuticals Appoints Elkan Gamzu, Ph.D., as Permanent CEO
EPIX  
Linked by BusinessWire - March 05, 06:30AM from (www.businesswire.com)
EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX) a biopharmaceutical company focused on discovering and developing novel therapeutics  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
EPIX Pharmaceuticals Announces Resignation of Chief Business Officer
EPIX  
Linked by BusinessWire - February 27, 06:30AM from (www.businesswire.com)
EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX) a biopharmaceutical company focused on discovering and developing novel therapeutics  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
EPIX Pharmaceuticals Announces Third Quarter Financial Results
EPIX  
Linked by BusinessWire - November 04, 06:30AM from (www.businesswire.com)
EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX) a biopharmaceutical company focused on discovering and developing novel therapeutics  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource